NO20074419L - Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom - Google Patents

Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom

Info

Publication number
NO20074419L
NO20074419L NO20074419A NO20074419A NO20074419L NO 20074419 L NO20074419 L NO 20074419L NO 20074419 A NO20074419 A NO 20074419A NO 20074419 A NO20074419 A NO 20074419A NO 20074419 L NO20074419 L NO 20074419L
Authority
NO
Norway
Prior art keywords
drugs
receptor antagonists
manufacture
endothelin receptor
fight disease
Prior art date
Application number
NO20074419A
Other languages
English (en)
Inventor
Klaus Muenter
Michael Kirchengast
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20074419L publication Critical patent/NO20074419L/no
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Anvendelse av endotelinreseptor-antagonister for å produsere medikamenter for å kontrollere fedme og sykdommer forårsaket av fedme. ?? ?? ?? ?? 1
NO20074419A 1997-12-05 2007-08-30 Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom NO20074419L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit
PCT/EP1998/007501 WO1999029308A2 (de) 1997-12-05 1998-11-21 Methode zur bekämpfung der fettleibigkeit

Publications (1)

Publication Number Publication Date
NO20074419L true NO20074419L (no) 2000-06-02

Family

ID=7850913

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20002777A NO324694B1 (no) 1997-12-05 2000-05-30 Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi.
NO20074419A NO20074419L (no) 1997-12-05 2007-08-30 Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20002777A NO324694B1 (no) 1997-12-05 2000-05-30 Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi.

Country Status (16)

Country Link
US (1) US6197780B1 (no)
EP (1) EP1035851B1 (no)
JP (1) JP2002512173A (no)
KR (1) KR20010032779A (no)
CN (1) CN1152685C (no)
AT (1) ATE204172T1 (no)
AU (1) AU751053B2 (no)
BR (1) BR9815335A (no)
CA (1) CA2311423C (no)
CZ (1) CZ300442B6 (no)
DE (2) DE19754082A1 (no)
ES (1) ES2162493T3 (no)
HU (1) HUP0100171A3 (no)
NO (2) NO324694B1 (no)
RU (1) RU2292891C2 (no)
WO (1) WO1999029308A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
CA2697057A1 (en) 2007-08-22 2009-02-26 Gilead Colorado, Inc. Therapy for complications of diabetes
MX370976B (es) 2011-11-11 2020-01-10 Gilead Apollo Llc Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos.
WO2016099233A2 (ru) * 2014-10-20 2016-06-23 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
PL3380479T3 (pl) 2015-11-25 2023-05-08 Gilead Apollo, Llc Triazolowe inhibitory acc i ich zastosowania
US20170166582A1 (en) 2015-11-25 2017-06-15 Gilead Apollo, Llc Pyrazole acc inhibitors and uses thereof
EP3380478B1 (en) 2015-11-25 2020-12-23 Gilead Apollo, LLC Ester acc inhibitors and uses thereof
CN108347939B (zh) 2015-11-25 2021-09-28 吉利德阿波罗公司 含有2,4-二氧代-1,4-二氢噻吩并[2,3-d]嘧啶的衍生物的杀真菌组合物
CA3155220C (en) 2016-03-02 2024-01-16 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
ES2982801T3 (es) 2017-03-28 2024-10-17 Gilead Sciences Inc Combinaciones terapéuticas para el tratamiento de las enfermedades hepáticas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950704314A (ko) 1992-12-01 1995-11-17 가와노 다케히코 1,8-나프티리딘-2-온 유도체 및 그 사용 방법(1,8-naphthyridin-2-one derivative and use thereof)
AU6603996A (en) 1995-08-24 1997-03-19 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
HUP0100171A2 (hu) 2003-02-28
EP1035851B1 (de) 2001-08-16
NO324694B1 (no) 2007-12-03
CN1301162A (zh) 2001-06-27
AU2153599A (en) 1999-06-28
EP1035851A2 (de) 2000-09-20
AU751053B2 (en) 2002-08-08
CZ20002006A3 (cs) 2000-11-15
ES2162493T3 (es) 2001-12-16
CA2311423C (en) 2008-01-29
KR20010032779A (ko) 2001-04-25
ATE204172T1 (de) 2001-09-15
BR9815335A (pt) 2000-10-17
HK1037141A1 (en) 2002-02-01
DE19754082A1 (de) 1999-06-10
WO1999029308A3 (de) 1999-09-30
NO20002777L (no) 2000-06-02
JP2002512173A (ja) 2002-04-23
HUP0100171A3 (en) 2003-10-28
US6197780B1 (en) 2001-03-06
RU2292891C2 (ru) 2007-02-10
CN1152685C (zh) 2004-06-09
CZ300442B6 (cs) 2009-05-20
WO1999029308A2 (de) 1999-06-17
NO20002777D0 (no) 2000-05-30
RU2003138080A (ru) 2005-06-10
CA2311423A1 (en) 1999-06-17
DE59801230D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
DK1588706T3 (da) Valsartantablet
EP1572972A4 (en) THERAPY OF NON-MALIGNER DISEASES OR DISORDER WITH ANTI-ERBB2 ANTIBODIES
FI20000720L (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
EE04630B1 (et) Tsentraalse kannabinoidretseptori antagonistide kasutamine ravimi valmistamisel apetentsi reguleerimiseks
MA22758A1 (fr) Antagonistes des recepteurs d'endotheline
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
EP0837927A4 (en) MONOCLONAL MONKEY ANTIBODIES AGAINST HUMANE B7.1 AND / OR B7.2 ANTIGEN, PRIMATIZED DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
FI960953L (fi) Endoteliinireseptoriantagonisteja
DE69814394D1 (de) Verwendung von levobupivacain
ITSV970008V0 (it) Apparecchio ortodontico per l'espansione e la contrazione ortodontica e ortopedica del mascellare superiore.
EP0832125A4 (en) Human g-protein receptor hgber32
BR0312683A (pt) Cápsulas de higiene oral
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
BR9815335A (pt) Uso de antagonistas de receptor de endotelina.
SE9700934D0 (sv) New formulation
EP0724387A4 (en) ANGIOTENSIN II RECEPTOR ANTAGONISTS
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
FI973578L (fi) Anatomisesti muotoiltu yhdistetty terveysside
EP1318822A4 (en) CELL IMPLANT THERAPY FOR NEUROLOGICAL DISORDERS OR DISEASES
ITTO950541A0 (it) Dispositivo per il controllo dell'odore.
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
DE69636597D1 (de) Endothelin rezeptor antagonisten
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
EP0835264A4 (en) Human g-protein receptor hcegh45
FI946006A7 (fi) Humaani-rinoviruksen reseptoriproteiinin multimeerisiä muotoja

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application